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resumo 
 
 
O osso é um tecido conjuntivo de extrema importância no organismo humano, 
tendo funções como suporte ou proteção de órgãos internos, sendo também 
metabolicamente relevante como o principal reservatório de minerais e 
assegurando a hematopoiese com a medula óssea. Dado o envelhecimento da 
população, tem-se verificado um aumento da incidência de doenças 
degenerativas deste tecido, sendo assim essencial aplicar terapias altamente 
eficientes para o tratamento dessas patologias. A Engenharia de Tecidos 
surge como uma tecnologia promissora no tratamento destes problemas, como 
a perda de massa óssea e problemas nas articulações. 
Neste trabalho, foram produzidos biomateriais compósitos, baseados numa 
matriz polimérica sob a forma de hidrogel reforçada com partículas de vidro 
bioativo. Individualmente, estes materiais apresentam um elevado teor em 
água favorável ao transporte de nutrientes, e propriedades osteogénicas, 
respetivamente. O polímero selecionado foi a pectina funcionalizada com 
RGD, dadas as suas propriedades interessantes como a biocompatibilidade, 
capacidade de promover a adesão celular e adequabilidade para o 
encapsulamento de células, e o vidro bioativo apresenta uma composição de 
70% de diópsido e 30% de fosfato tricálcico (Di-70) isento de alcalinos e sendo 
composto por SiO2, CaO, MgO e P2O5. 
Diferentes formulações de hidrogéis compósitos foram testadas, em que se 
variou a concentração de polímero, a concentração de biovidro e o seu 
tamanho de partícula. Analisaram-se as propriedades viscoelásticas dos 
biocompósitos, bem como o seu comportamento biológico, com ensaios de 
citotoxicidade, e ainda as propriedades osteogénicas do material, pela 
incubação de hidrogéis contendo células estaminais mesenquimais  (MSCs) em 
meio basal e osteogénico durante 21 dias. Os resultados deste trabalho 
indicam que foi possível preparar um biomaterial compósito de propriedades 
mecânicas ajustáveis, com capacidade de reticular in situ em tempos 
clinicamente desejáveis sem necessitar agentes reticulantes externos. Para 
além disso, as propriedades osteogénicas intrínsecas do biovidro forneceram 
as condições adequadas para a promoção da diferenciação de MSCs sem 
estimulação osteogénica adicional. As propriedades combinadas alcançadas 
indicam que os biocompósitos preparados têm potencial para ser aplicados em 
engenharia de tecido ósseo. 
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abstract 
 
Bone is an extremely important connective tissue in the human body, as it 
provides support and protection of internal organs, being also metabolically 
relevant as the main mineral reservoir and assuring haematopoiesis through 
the bone marrow. Due to the current ageing of the population, an increase in 
bone tissue related diseases is noticeable. Thus, more efficient therapies for 
treating bone diseases is crucial. Tissue Engineering appears as a promising 
technology for treating several of those problems, such as bone loss and joint 
problems. 
In the present work, composite biomaterials composed of a polymeric hydrogel 
matrix reinforced with bioactive glass particles were prepared. Individually, 
these materials have a high water content, which enhances their diffusive 
transport properties, and display osteogenic properties, respectively. The 
selected polymer was RGD functionalized pectin, due to its interesting 
properties, such as biocompatibility, cell-adhesive characteristics and adequacy 
for cell entrapment, and the bioactive glass selected was a novel alkali-free 
formulation of 70% diopside and 30% tricalcium phosphate (Di-70), composed 
of SiO2, CaO, MgO and P2O5.  
Several different composite formulations were tested, in which pectin 
concentration, bioactive glass content and glass particle size were varied. The 
biocomposite’s viscoelastic properties were assessed, as well as their 
biological behaviour through cytotoxicity assays, and osteogenic character by 
incubating mesenchymal stem cell (MSC)-laden composites into both basal 
and osteogenic media for up to 21 days. The results obtained demonstrated 
that a composite biomaterial with tuneable mechanical properties was 
successfully prepared, with in situ crosslinking ability within therapeutically 
relevant timeframes, and not requiring additional crosslinking strategies 
besides its own composition. Furthermore, its intrinsic osteogenic properties 
due to the glass composition provided the adequate conditions for promoting 
the differentiation of MSCs without osteogenic stimulation. The combined 
properties achieved indicate that the biocomposites prepared are suitable 
candidate cellularized biomaterials for bone tissue engineering applications. 
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Chapter 1 
Introduction 
 
 
 
1.1 Framework 
 
In the last century an increase in life expectancy has been observed, especially in 
developed countries, due to the advances in medicine and medical technology in general 
[1]. However, this rise in life span also results in population ageing which, aggravated by a 
sedentary lifestyle, results in an increase in the incidence of degenerative musculoskeletal 
diseases such as osteoarthritis and osteoporosis. Therefore, there is a growing need for 
highly efficient treatments for these bone diseases, this constituting the driving force 
towards the development of new and improved bone regeneration strategies, namely grafts 
and scaffold materials for application in regenerative medicine [1, 2]. 
Tissue engineering (TE) is a viable option for the treatment of the aforementioned 
illnesses, combining the principles of engineering, biology and chemistry in order to obtain 
a biological substitute that restores, maintains or improves a damaged tissue or organ. This 
multidisciplinary field combines living cells, biologically active molecules and a physical 
support in the form of a scaffold to promote cell migration, colonization, growth and 
differentiation, as well as to increase vascularization and thus allow the ingrowth of new 
tissues [1-3]. 
Scaffolds for TE should present a three-dimensional porous structure (with 
adequate pore size and interconnectivity), suitable mechanical properties matching those of 
the host tissue in which they will be implanted and they should be biodegradable, ideally 
with a degradation rate as similar as possible to new tissue regeneration rate [1, 4]. As 
such, the scaffold’s material choice is of extreme importance, as they should fulfil these 
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requirements, and additionally be biocompatible, i.e., not eliciting any adverse reactions, 
namely immune reaction in order to avoid acute inflammatory responses that compromise 
healing or cause rejection by the body, besides allowing for cells to adhere, proliferate and 
grow without compromising their normal metabolic activity [5]. 
In bone tissue engineering there are several materials that meet the above 
requirements and show favourable results, especially polymers and ceramics. Ceramic 
scaffolds made of calcium phosphates or bioactive glasses, for example, have appropriate 
mechanical properties for bone applications, as well as excellent chemical compatibility, 
due to the similarity with bone’s structural composition [1, 5]. On the other hand, natural 
polymeric hydrogels such as collagen, alginate and pectin, have also been widely used in 
biomedical applications, mainly due to their biodegradability, versatility in terms of 
biochemical composition and processability, and consequent adequacy as cell carriers [5, 
6]. The possibility to create composite materials merging two or more different materials 
combines each separate material’s relevant properties and attenuates their disadvantages. 
Moreover, bone is intrinsically a composite material, whose structure is mainly composed 
of hydroxyapatite and collagen, making composite scaffolds attractive options for bone TE 
[7]. 
The processing technique is also an important step in developing a material for TE, 
as it can greatly influence the final properties of the materials. It is essential for the method 
not to negatively influence the material’s inherent properties, such as biocompatibility or 
chemistry, and it should also provide accurate and consistent processing, avoiding batch to 
batch variability when scaffolds are processed with the same conditions and parameters 
[8]. 
 
 
 
1.2 Objectives 
 
The present work aims at the production of three-dimensional structures made of a 
natural polymeric hydrogel reinforced with bioactive glass particles and the evaluation of 
their mechanical and biological properties to assess their suitability for bone tissue 
engineering applications. 
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The specific objectives include: i) preparation and processing of the scaffolds’ raw 
materials (pectin and bioactive glass); ii) production composite hydrogels with different 
formulations in terms of polymer and glass content and glass particle size; iii) 
characterization of composite’s rheological properties and swelling profiles; iv) cell 
entrapment within the composites and evaluation of their biological behaviour through in 
vitro assays of cytotoxicity, metabolic activity, proliferation and differentiation. 
 
 
 
1.3 Dissertation Structure 
 
The present dissertation is divided into 5 main chapters. In Chapter 1 the 
framework of the dissertation and its objectives are presented. Chapter 2 includes a 
relevant literature review in order to provide context and explain and justify the relevance 
of this work. Chapter 3 covers the materials and methods used in the experimental part of 
the project, including details about the production and processing of materials, and the 
methodologies used to characterize them, including the biological in vitro tests. In 
Chapter 4 the results obtained are presented, analysed and discussed. Finally, Chapter 5 
will serve as a conclusion to the work carried out, compiling and summarizing the obtained 
data, allowing for an introspection of the main aspects learnt and includes proposals of 
possible future work. 
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Chapter 2 
Literature Review 
 
 
 
2.1 The bone 
 
Bone, alongside cartilage, ligaments, tendons and joints, form the skeletal system, 
which is responsible for the support and protection of inner organs of the human body, for 
allowing the movement of the body, for storing minerals and for producing blood cells in 
the bone marrow. The average adult skeleton has 206 bones distributed along the whole 
body: skull, torso and limbs. This number may vary person to person, and tends to decrease 
with age due to fusion of some bones [9]. 
Just as other connective tissues, bone tissue consists of cells and extracellular 
matrix. This matrix is composed of approximately 35% organic material (mainly collagen 
and proteoglycans) and 65% inorganic material (primarily a calcium phosphate called 
hydroxyapatite (HA), with the molecular formula Ca10(PO4)6(OH)2). Bone properties are 
highly influenced by the equilibrium of these constituents, as collagen provides flexibility 
and the mineral component offers compression strength. On one hand, if the organic part is 
removed, bone becomes very brittle and, on the other hand, if the minerals are removed, it 
will become overly flexible [9]. 
Bone cells control bone functions and can be categorized into three different types: 
osteoblasts, osteoclasts and osteocytes. Osteoblasts are responsible for the production of 
new bone matrix in a process called osteogenesis (or ossification). These cells remain 
active for about eight days, producing fibres and matrix until they are completely 
surrounded by extracellular matrix, maturing and developing into osteocytes, which are 
sensitive to mechanical stimuli and maintain the bone matrix. Osteoclasts are responsible 
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for the resorption of bone. An equilibrium between osteoblastic and osteoclastic activity is 
essential to preserve bone properties, in a process called bone remodelling [9, 10]. 
It is also essential to distinguish between compact (or cortical) and spongy (or 
cancellous) bone (Figure 1), which are the two macroscopic types of bone tissue. Spongy 
bone has a porous appearance and consists of a fine net of interconnecting bone rods called 
trabeculae. In long bones, the spaces between trabeculae hold blood vessels that irrigate the 
bone and bone marrow, allowing for a higher remodelling rate than that of the compact 
bone. This latter class of bone is much denser and has fewer spaces than spongy bone. It is 
constituted by concentric lamellae that surround blood vessels, forming structures named 
osteons. About 80% of total bone mass is constituted by compact bone [9, 10]. As a 
consequence, these two types of bone display very different characteristics, including very 
distinctive mechanical properties, contributing to the tissue’s torsional, flexible and 
compressive strengths [10]. Table 1 summarizes some of those properties. 
 
 
 
Figure 1 – Spongy bone structure (Adapted from [9]) 
 
 
  
 
Manuel João Barros  Chapter 2 – Literature Review 
 
7 
 
 
Table 1 – Mechanical properties of compact and spongy bone (Adapted from [11]). 
Mechanical property Compact bone Spongy bone 
Compressive strength (MPa) 130 – 200 0.1 – 16 
Compressive modulus (GPa) 11.5 – 17 0.12 – 1.1 
Young’s modulus (GPa) 7 – 30 0.05 – 0.5 
 
 
Bone’s mechanical properties are influenced by several factors such as age, gender 
and general health of the individual. This fact, associated with the fact that bone is an 
anisotropic material, which results in variable mechanical properties according to the 
load’s direction, might explain the inconsistency of mechanical properties’ values found in 
the literature [10]. 
Bones can also be classified according to their shape. They can be long (such as the 
femur and the ulna), short (including carpal and tarsal bones, with nearly cubic shapes), 
flat (like the ones found in the skull) or irregular (such as the vertebrae). Long bones are 
composed by different parts, namely the diaphysis, the epiphysis and, in growing bones, 
the epiphyseal plates. These cartilaginous plates are replaced by bone in structures called 
epiphyseal lines when bone growth stops (Figure 2). The diaphysis can be considered the 
body of the bone and is primarily composed of compact bone; on the other hand, the 
epiphysis is composed of spongy bone with an external layer of compact bone. In long 
bones’ diaphysis there can be a large internal space called the medullary cavity, which is 
filled with yellow bone marrow [9]. Due to being more susceptible to bending moments, 
long bones are more prone to suffer fractures [10]. 
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Figure 2 – Structure of an adult long bone (femur): A) Epiphysis; B) Internal features of the 
diaphysis (Adapted from [9]) 
 
 
Due to the combination of the above described characteristics, bones are one of the 
hardest and sturdiest structures in the human body, second only to dentin’s enamel. They 
are also one of the most dynamic and metabolically active tissues, displaying activity 
throughout all stages of life. Bones are sensitive to mechanical loads, which can alter their 
density, configuration and general properties, and exhibit an excellent self-reparation 
capability in case of trauma or fracture [10]. 
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2.1.1 Bone renewal and remodelling 
 
Bones can remodel, i.e., they can adjust by resorbing old tissue and producing new 
bone tissue in different places, modifying their morphology according to the varying 
mechanical conditions they are exposed to. Osteocytes, as mentioned before, have a 
predominant role in this process due to being sensitive to mechanical stimuli [10]. Bone 
remodelling is linked to bone growth and is influenced by genetic factors, nutrition and 
hormones [9]. Bone growth’s processes (resorption and formation of bone tissue) are not 
balanced, resulting in shape, mass and microarchitecture modifications [10]. 
Annually, around 10% of total bone mass is replaced in adults due to the 
remodelling process, which helps prevent the accumulation of microfissures, thus repairing 
the small damage induced by the cyclic mechanical stress applied to the bones. Moreover, 
bone remodelling helps to maintain optimal calcium levels in the blood [10]. This process, 
as mentioned earlier, is reliant on a coordination of osteoblastic and osteoclastic activity. 
These cells form temporary assemblies called basic multicellular units that travel through 
and across the surface of the bone, removing old matrix and replacing it with new one, 
which lets the tissue renew itself without changing its morphology or density [10, 12]. It is 
a mechanism that includes a sequence of well-defined events that include the activation of 
osteoclasts with consequential resorption of bone tissue, followed by osteoblasts’ 
activation which will form new bone at the site of resorption [12]. Remodelling rates vary 
throughout life, being higher during childhood. It is also greater (about five times) in 
spongy bone compared to compact bone [10]. 
These processes are of extreme importance in order to maintain bone properties and 
repair small defects. However, for larger defects, human intervention is required to aid or 
stimulate the healing [12]. 
 
 
2.1.2 Bone defect repair 
 
The natural process of bone fracture recovery is a complex procedure that begins as 
soon as the fracture occurs, evolving towards its consolidation. This mechanism is different 
for compact bone and for spongy bone. For the former, the process is similar to the scar 
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formation in the healing process of a skin wound. Bone’s vascularization plays a crucial 
role, as different vessels may be affected depending on fracture site [10]. 
The repairing process of a long bone has three main stages: the inflammatory 
phase, the repair phase and the remodelling phase (Figure 3). The first stage has a two to 
three-week duration and leads to the formation of a hematoma, as a result of surrounding 
blood vessel damage, followed by an inflammatory reaction. Fractured surfaces can also 
suffer necrosis, which extent depends on the degree of soft tissue damage and on the 
distance separating the affected surfaces. After the hematoma, a clot is formed to stop the 
bleeding. Afterwards, the recovery phase begins with the formation of the callus, which 
connects the broken ends of the bone, promoting their union. The callus forms as the clot 
dissolves, between the fourth and eighth week after the fracture happens. It has an internal 
component, which replaces the hematoma, and an external component that helps stabilize 
the bone. At this point, immobilization of the fracture site is crucial to avoid complications 
due to excessive movement. Then, ossification of the callus occurs by the deposition of 
new collagenous matrix and calcium phosphate salts, which creates an immature, woven 
bone with no well-defined structure. Finally, the bone remodelling process initiates, 
allowing the woven and necrotic bones to be replaced with new compact bone, completing 
the fracture repair process [9, 10]. 
 
 
Figure 3 – Stages of bone fracture repair process (Adapted from [9]) 
 
 
Hence, bone defect repair is a biologically and mechanically complex process 
which can and should be facilitated by human intervention. There are several different 
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approaches to help repair an injured bone, such as bone grafts (natural or artificial) or 
tissue engineering (TE) strategies. Natural grafts can be divided into three major 
categories: autografts, allografts and xenografts. Each option offers different advantages 
and disadvantages [13]. Autografts remain the gold standard in many small defect cases, 
and coming from another part of the patient’s body, they minimize incompatibility issues 
or disease transmission risk. They present ideal osteogenic properties, but require two 
different surgeries, which encompass two separate scarring processes, increases infection 
risk and result in high pain and donor site morbidity, as well as higher blood loss [13-16]. 
Allografts are a common alternative to autografts due to reducing the morbidity of the 
process, since they are obtained from a different individual of the same species. Another 
benefit of the use of allografts is the possibility to perform local anaesthesia. However, 
these grafts have inferior osteogenic and osteoinductive properties, and their processing 
also weakens their biological and mechanical properties. Furthermore, they are more likely 
to induce immune system response and face other problems regarding ethics and waiting 
lists [13, 17, 18]. Finally, the last natural option are xenografts, whose source is an 
individual from another species. The main advantages of the use of xenografts include the 
low costs and the highly available resources associated. However, they carry the same 
disadvantages as allografts, and additionally carry the risk of zoonotic diseases 
transmission and are more likely to be aggressively rejected by the body [13, 19, 20]. 
Artificial grafts, or synthetic biomaterial-based substitutes, have been showing 
promise in decreasing natural graft’s drawbacks [13]. An artificial bone graft can be 
defined as an implantable material that promotes the regeneration of bone tissue via 
osteogenesis, osteoinduction and osteoconduction. These grafts can have different origins, 
and the selection depends on several factors including tissue viability, defect size (as well 
as its shape and volume), biological and biomechanical properties, cost and ethical issues 
[13]. The most commonly used artificial grafts in bone TE are either polymeric (such as 
collagen, chitosan, alginate or polylactic acid) or ceramic (for instance, bioactive glasses, 
HA or different calcium phosphates) and even though they show promising results, the low 
mechanical properties, reduced osteogenic properties and unpredictable dissolution rates 
hinder their usability [13, 21].  
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To circumvent the above-mentioned drawbacks of natural and artificial grafts, TE 
strategies and the development of novel materials and technologies provide new and 
improved alternatives for efficient bone regeneration. 
 
 
2.2 Tissue engineering 
 
Tissue engineering is an expanding field whose objective is the production of 
biological substitutes that restore or improve tissue and organ function. The term “Tissue 
engineering” was defined by Langer and Vacanti as a multidisciplinary field that applies 
engineering and life science’s principles and methods to better understand the connection 
between tissue structure and function and to develop biological substitutes that repair, 
maintain or improve tissues [5, 22]. Hence, this branch of regenerative medicine presents 
itself as an interdisciplinary field that combines knowledge from medicine, engineering, 
materials science, chemistry, genetics, biology and all related [5, 23]. 
The basis of TE is the combination of live cells, biologically active molecules (for 
example, growth factors, hormones or genes) and a three-dimensional construct capable of 
supporting the colonization, migration, growth and differentiation of cells in order to 
regenerate malfunctioning tissues (Figure 4) [1]. 
 
 
Figure 4 – Principles of Tissue Engineering (Adapted from [5]). 
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The three-dimensional structure is obtained through the construction of a scaffold 
that works as a physical support for cells, providing an application-specific 
microenvironment, as well as serving as water, nutrients and other important molecules 
reservoir [8]. These constructs must be biocompatible, biodegradable and should have 
appropriate mechanical properties and architecture. It is also required that processing 
techniques do not negatively influence the scaffolds’ characteristics [5]. 
Biocompatibility is a vital criterion that must be fulfilled by any biomaterial for TE. 
It is described as the ability of a material to induce cell adherence to its surface, allowing 
them to proliferate and differentiate, without causing an acute inflammatory reaction at the 
time of implantation that could possibly compromise the success of the therapy through 
reduction of healing capability or material rejection [5, 22]. 
Biodegradability is also a fundamental characteristic of scaffolds used in TE, as its 
main goal is to aid patient’s self-healing process. As such, and ideally, the degradation rate 
of implanted scaffolds should be as close as possible to host tissue’s regenerative rate, 
namely extracellular matrix production by the cells. It is essential that the by-products of 
their degradation are non-toxic as well, and they should be able to easily exit the body 
without interfering with other organs [5, 24, 25]. 
Scaffolds’ mechanical properties should mimic, as far as possible, the properties of 
the tissue they will be implanted on, this remaining one of the biggest challenges in TE, 
especially in cardiovascular and orthopaedic applications. They should also be resistant to 
the handling during the surgical implantation [3, 5]. In bone tissue regeneration, one 
consequence of the discrepancy between the mechanical properties of the bone and the 
biomaterial is designated as stress-shielding effect, which can be described as an 
adaptation of the host tissue to constant localized disuse as a result of reduced mechanical 
stimuli. This causes a higher resorption of bone tissue at the area surrounding the implant, 
leading to bone mass loss [10]. 
The design of the scaffold is also extremely important. Scaffolds should be highly 
porous so as to increase its surface area and to enable cell proliferation, tissue 
vascularisation and adequate oxygenation. The pores should also be interconnected in 
order to allow for cell migration and proper angiogenesis [5]. Pore size may vary, being 
that both micro and macroporosity influence osteogenesis [8]. 
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Scaffold fabrication technique is another relevant factor to take into consideration, 
since it should be possible to scale-up from making single units into producing bigger 
batches without affecting the economic viability of the process, in order to create a 
clinically and commercially sustainable material [5]. 
The three-dimensional structure is especially important since tissues and organs are 
three-dimensional as well. This more complex morphology is crucial in maintaining cell 
viability, influencing their shape, gene expression, growth, mobility and differentiation, as 
cells and their extracellular matrix interact strongly. All these features can also be 
regulated with the addition of growth factors, cell adhesion molecules or hormones to the 
material’s composition [26, 27]. 
Growth factors and hormones are biomolecules capable of stimulating new bone 
formation, for example, by enhancing osteogenesis and angiogenesis [28, 29]. 
Bhattacharjee et al. (2016) showed that the use of a combination of different growth 
factors (transforming growth factor beta and bone morphogenetic protein-2) lead to an 
increase in MG-63 cell activity, proliferation and differentiation, higher calcium deposition 
and greater expression of bone growth related genes [30]. 
Some scaffold materials do not intrinsically interact with cells. In that case, it is 
possible to potentiate cell adhesion by modifying the material with molecules such as 
peptides containing the amino acid sequence arginine-glycine-aspartic acid (RGD), which 
interacts with the integrins present in cell’s cytoplasmic membrane [24, 31]. 
The choice of the cells to use in TE applications also influences the therapeutic 
success. Stem cells, and specifically human mesenchymal stem cells (hMSCs), have been 
recognized as a promising cell source for bone tissue engineering. When under appropriate 
in vitro conditions (within ceramic or polymeric matrixes with the adequate 
characteristics), these multipotent progenitor cells can be induced to differentiate into 
adipocytes, chondrocytes or osteoblasts [32, 33].  
Thus, TE allows for a great amount of possibilities, depending on the desired 
application. As such, the choice of biomaterials to use should be taken into account, as they 
are a central part of these therapies. 
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2.3 Biomaterials 
 
According to the American National Institutes of Health, a biomaterial is any 
natural or synthetic substance or combination of substances, other than drugs, that can be 
used for any amount of time, and whose purpose is to totally or partially enhance or 
replace any tissue, organ or function in order to improve the quality of life of an individual 
[34]. 
Biomaterials can be classified into the four main classes of materials, i.e., metals, 
ceramics, polymers and composites, differing in their properties and possible applications. 
Metals are strong and usually inert materials but who suffer from oxidation [34]. Ceramics 
can be of natural (for instance, HA) or synthetic (such as bioactive glasses) origin, and are 
very hard but brittle materials who often show bioactivity and biodegradability [34-36]. 
Polymeric materials, as ceramics, can be natural (collagen and chitosan for example) or 
synthetic (polylactic acid, polycaprolactone, polymethyl methacrylate among others). They 
are light, versatile and often biodegradable materials [34, 35]. Finally, composites are 
materials that combine two or more different materials, assembling the positive 
characteristics of each component and overcoming their limitations [34, 35, 37-39]. 
Biomaterial usage began around 1950, where the materials were mainly inert and 
selected for provoking minimal reactions in the host tissue. This is considered the first 
generation of biomaterials, and an example of a successful application is the total hip 
replacement still currently practiced. One of the materials used for total hip replacements at 
the time was austenitic stainless steel, as it was resistant to corrosion and showed appealing 
mechanical properties [34]. 
The second generation of biomaterials began around 1970 with the need to find 
materials that would interact with living tissues. Novel bioactive materials emerged in this 
generation of biomaterials, used either as bulk or as coatings for other materials, in order to 
improve the implant-tissue interface [34, 40]. 
Alongside the concept of tissue engineering, the third generation of biomaterials 
arose, in which the material’s main goal was to enhance tissues’ self-regeneration instead 
of simply replacing them [34, 41]. 
All biomaterials share common features, such as being biocompatible, 
biofunctional, i.e., having adequate physical and chemical properties for their desired 
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application, as well as being sterilizable [34]. Sterilization is indispensable for any 
surgically inserted material in the human body, and can be a problematic process for some 
materials, namely polymeric ones, as some traditional sterilization techniques may alter 
some of their properties in undesirable ways [42]. 
Some materials may also be bioactive, as mentioned previously. This feature is 
mostly found in ceramics and can be defined as a material’s ability to interact and bond to 
surrounding tissues, generating an environment that is favourable to osteogenesis. 
Bioactive implants and grafts form a layer of hydroxyapatite at the surface, creating a 
strong interface between bone and material [43]. 
Thereby, biomaterials can be classified according to the type of interaction with the 
host tissue, as summarized in Table 2. 
 
Table 2 – Types of implant-tissue interactions (Adapted from [43]) 
Property Type of attachment Biomaterial 
Nearly inert 
Morphological fixation 
(mechanical interlock) 
Metals, alumina, 
zirconia, polyethylene 
Porous 
Biological fixation 
(growth of tissues into the pores) 
Hydroxyapatite, 
coated porous materials 
Bioactive 
Bioactive fixation 
(interfacial bonding with tissues) 
Bioactive glasses, hydroxyapatite, 
glass-ceramics 
Resorbable 
Replacement of the material with 
new tissue 
Tricalcium phosphates, 
polylactic acid 
 
Several biomaterials meet the biological and technological criteria to be used in 
bone tissue engineering, although ceramic materials are usually favoured. As previously 
stated, these can be of natural origin (e.g., coralline HA) or synthetic (as β-tricalcium 
phosphate), and their advantages include osteoconductive and osteoinductive properties 
[8]. However, their mechanical instability and unpredictable dissolution rates can be 
problematic, as these factors can contribute to cellular death due to a rise in extracellular 
calcium and phosphorus concentrations [8, 44]. 
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Bioactive glasses have been gradually introduced as alternatives for bone tissue 
regeneration because of their development and success since the discovery of 45S5 
Bioglass® by Larry Hench [45]. New formulations have been created aiming to improve 
this material’s properties and expand its uses [46]. Section 2.3.1 will develop this topic in 
more detail. Polymers are also widely used in bone TE, both natural (as collagen, alginate, 
chitosan and pectin) and synthetic (e.g., PGA, PCL and PLA) [6, 23]. However, and taking 
into account bone’s own composite structure, there has been a growing interest in the use 
of composite materials for bone tissue engineering. Some formulations consist of calcium 
phosphate hybrids, such as HA combined with different polymers, showing evidence of 
promising results in terms of mechanical properties, and with augmented osteogenic ability 
due to the ceramic’s mineralization capabilities [3, 7].  
 
 
2.3.1 Bioactive glasses 
 
Bioactive glasses were discovered around 1969, when Larry Hench developed the 
45S5 Bioglass® [45]. This glass has a specific composition of 45% SiO2, 24.5% CaO, 
24.5% Na2O and 6% P2O5 (wt %), which allows it to establish strong bonds with hard 
tissues, thus creating the concept of bioactivity. 45S5 Bioglass® is therefore considered by 
many as the pioneer of bioactive materials, leading to the development of several new 
formulations [43, 45, 46]. 
Hench also proposed a series of steps that sequentially describe what happens at the 
surface of bioactive materials when in physiological environments. They are as follows 
[47, 48]: 
1. Ionic exchange between the material’s Na+ and the fluid’s H+ and H3O+; 
2. Dissolution of silica into the fluid (Si(OH)4) and establishment of Si–OH 
bonds at the material’s surface; 
3. Condensation of the silica-rich coating in the material’s surface; 
4. Adsorption of Ca + PO4 + CO3 + OH to the previously formed silica layer, 
with development of an amorphous layer rich in CaO and P2O5; 
5. Crystallization of a carbonated HA layer; 
6. Adsorption of biological molecules to the HA surface; 
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7. Macrophage action; 
8. Cell adhesion; 
9. Cell differentiation; 
10. Extracellular matrix production; 
11. Mineralization of the newly formed matrix. 
 
Nevertheless, 45S5 Bioglass® is not free from flaws, as some hindrances have been 
reported, such as its easy dissolution in an aqueous environment, which leads to a decrease 
in bioactivity and an increase in pH due to the high sodium concentrations. This fact can 
hinder natural processes such as bone remodelling, compromising the effectiveness of the 
therapy [1, 12]. 
Hence, new formulations of glasses and other bioactive ceramics have been 
developed and commercialized, in an attempt to overcome its drawbacks [47]. A 
summarized list of examples of these materials and their compositions is provided in Table 
3. 
 
Table 3 – Examples of commercialized bioactive glasses and glass -ceramics and their respective 
compositions (wt %) (Adapted from [46, 47]) 
Bioactive glasses SiO2 P2O5 CaO Ca(PO3)2 CaF2 MgO Na2O K2O Al2O3 B2O3 TiO2 
45S5 Bioglass® 45.00 6.00 24.50 - - - 24.50 - - - - 
45S5.4F Bioglass® 45.00 6.00 14.70 - 9.80 - 24.50 - - - - 
45B15S5 Bioglass® 30.00 6.00 24.50 - - - 24.50 - - 15.00 - 
52S4.6 Bioglass® 52.00 6.00 21.00 - - - 21.00 - - - - 
55S4.3 Bioglass® 55.00 6.00 19.50 - - - 19.50 - - - - 
KGC Ceravital® 46.20 - 20.20 25.50 - 2.90 4.80 0.40 - - - 
KGS Ceravital® 46.00 - 33.00 16.00 - - 5.00 - - - - 
KGy213 Ceravital® 38.00 - 31.00 13.50 - - 4.00 - 7.00 - 6.50 
A/W glass-ceramic 34.20 16.30 44.90 - 0.50 4.60 - - - - - 
FastOS®BG 38.84 13.37 33.98 - 0.77 13.03 - - - - - 
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In the present work, a bioactive glass from the CaO–MgO–SiO2–P2O5 system was 
used. It is based in two components of interest: diopside (Di, CaOMgO2SiO2) and 
tricalcium phosphate (TCP, 3CaOP2O5). This formulation results in an alkali-free 
bioactive glass, which offers a slower and more controlled dissolution rate [49]. Diopside 
is a member of the pyroxenes’ class and presents favourable mechanical properties and 
bioactivity. Additionally, TCP is a resorbable calcium phosphate with known applications 
in bone tissue engineering for its excellent osteogenic properties [50]. The selected glass 
composition for this work (70% Di – 30% TCP, wt %) hereafter referred to as Di-70, 
corresponds to the following molar composition: 36.52% CaO, 19.24% MgO, 38.48% SiO2 
and 5.76% P2O5 [49]. Previous studies using this bioactive glass indicate that it is highly 
bioactive and osteogenic, stimulating the differentiation of mesenchymal stem cells into 
bone tissue cells [50]. 
 
 
2.3.2 Pectin 
 
In the present work, composite materials prepared from Di-70 bioactive glass and 
pectin will be produced. Pectin is a naturally derived polymer that constitutes 30% of 
higher plants’ cell walls. It is widely used in the food industry, namely as a stabilizer, 
emulsifier, thickener and gelling agent [6, 51]. However, it also shows promise in the 
biomedical and pharmaceutical fields, for instance in colon drug delivery systems, as it is 
specifically degraded by the anaerobic bacteria present in the intestine. It also shows 
interesting mucoadhesive properties, forming bonds with the mucin, which allows for a 
better control of its residence time in the body and enables the use of lower drug 
concentrations or doses [52, 53]. Its perspective applications include TE and its advantages 
include the ease of obtention, low cost, biocompatibility, non-toxicity and the fact that it 
induces the nucleation of mineral phases while under osteogenic conditions [53, 54]. 
Commercially available pectin is mainly obtained from apple pomace and citrus 
fruits’ peel through an acidic aqueous extraction process [54]. Pectin extracts obtained 
from plants’ cell walls share some common features, being predominantly composed of a 
homopolymer of (1-4)-linked-α-D-galacturonic acid (GalA) units that can be partially 
esterified on the carboxyl group and by the acetyl group on the secondary hydroxyls. 
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Pectins can be classified regarding their degree of methylation (DM), where low-methoxyl 
pectins present a DM < 50% and high methoxyl pectins show a DM > 50% [51]. This 
polymer’s properties are affected by its molecular weight and degree of esterification, thus 
the selection of the pectin source should be carefully made, since pectins of different 
origins may be more or less suitable for biomedical applications [53, 55]. 
Low-methoxyl pectins in solution can form hydrogels when in the presence of 
divalent metal ions such as calcium (Ca2+) (Figure 5) [51-57]. Calcium ions induce 
chain-chain associations that constitute junction zones responsible for the formation of gels 
in a model known as the egg-box model [58]. 
 
 
Figure 5 – Formation of a pectin hydrogel through ionic crosslinking (Adapted from [58]) 
 
Hydrogels are highly hydrated structures composed of hydrophilic polymeric 
chains that have a wide range of uses in TE due to their similarity to extracellular matrices 
by virtue of their high water content, which enhances viscoelastic properties and diffusive 
transport capability [51]. There are two possible methods to produce pectin hydrogels: 
external and internal gelation. The former is achieved by extruding droplets of a pectin 
solution into a calcium-rich solution, which allows the production of polymeric particles 
and beads due to the fast crosslinking reaction [6]. On the other hand, internal gelation 
allows the fabrication of scaffolds suitable for TE, since it produces homogeneous gels 
from the mixture of a poorly soluble calcium salt (e.g., calcium carbonate, CaCO3) into the 
polymeric solution with an acidification mechanism that promotes a slow release of 
calcium and the resulting crosslinking [6, 51]. 
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RGD-modified alginate and pectin biomaterials, who share many common features 
(although alginate is more commonly used), have also shown promising results in the 
differentiation of mesenchymal stem cells into bone cells when cultured in osteogenic 
conditions by providing an appropriate microenvironment for cellular attachment, growth 
and proliferation, making them suitable for bone tissue engineering applications by 
combining them with the bioactive glass [51, 59-63]. 
 
 
2.3.3 Hydrogel and bioactive glass composites 
 
The use of composite materials in bone tissue engineering is a widely studied 
strategy that shows promising results due to bone’s own composite composition. The most 
common approach is the use of polymer matrices reinforced with calcium phosphates (such 
as HA and TCP), as the study of bioactive glasses is still a growing field [64-66]. There are 
several studies focusing on biocomposites of this kind, with varying percentages of 
ceramic (from 0.1 to up to 87, wt %), different porosities and pore sizes and, consequently, 
diverse mechanical properties [67-69]. 
As previously mentioned, both bioactive glasses and hydrogels show interesting 
and appealing properties for TE. However, these materials present some drawbacks when 
used alone, which suggests that composites might mitigate those issues. With hybrids of 
polymers and bioactive glasses, it is possible to obtain materials with more adequate 
properties for bone tissue engineering, namely in terms of toughness and plasticity 
(provided by the polymeric phase) and in terms of osteogenic properties and compressive 
strength (provided by the mineral component) [70]. Moreover, the combination of these 
two materials is expected to result in an additional benefit, which relies in the crosslinking 
potential provided by the bioceramic, through the release of calcium and magnesium from 
its composition, both divalent cations that can induce the formation of the egg-box 
junctions in the pectin hydrogel [64]. 
Significant research efforts have been dedicated to develop this type of composites 
in injectable forms, in which the processing techniques and desired properties are highly 
different from those designed for three-dimensional scaffolds, especially regarding the 
rheological profiles, since the final products are microspheres or pastes [60, 70, 71]. 
  
 
Manuel João Barros  Chapter 2 – Literature Review 
 
22 
 
 
Polymer-glass ceramic composite scaffolds for TE may be ceramic-based impregnated 
with polymers, or polymer-based (for instance, hydrogels) with bioactive glass particles as 
reinforcement [65]. For the latter, the structure’s mesh size, mechanical and thermal 
properties, polymer-to-ceramic ratios, dissolution profile, ability to promote cell adhesion, 
mineralization inducing properties, as well as the particles’ morphology, size and 
microstructure are extremely important and need to be taken into consideration when 
designing a biomaterial [3, 65, 70-72]. More specifically, two major factors that are usually 
investigated to characterize the biocomposites are the percentage of bioactive glass content 
and the size of its particles. In general, glass content seems to highly influence the 
mechanical properties of the materials, which makes it an important parameter to control in 
order to achieve the desired characteristics, and particle size mainly affects the material’s 
osteogenic ability, in which smaller particles (nanoscale) appear to induce better responses 
[73-76]. 
In summary, several diverse formulations have been studied, and some examples 
include the use of 45S5 Bioglass® with different polymers (such as collagen or gelatine), 
FastOs®BG with polycaprolactone or even different bioactive glasses with a polymer of 
bacterial origins (gellan gum), all showing promising results for bone TE [1, 3, 65, 70, 77]. 
Some studies also report the use of this type of composite for drug delivery therapeutics or 
the use bioactive glasses doped with metal ions such as copper or strontium with promising 
results, suggesting that it might be possible to incorporate other compounds with 
anti-inflammatory, anti-bacterial and angiogenic properties into these composite materials 
[3, 66, 78]. From the analysis of the literature it is noticeable that pectin and bioactive glass 
composite scaffolds are still unexplored formulations. 
 
 
2.4 Processing techniques 
 
After selecting the suitable materials for a specific TE application, it is important to 
choose the ideal processing technique, taking into account factors such as costs, 
reproducibility and ability to preserve the raw material’s desired properties (such as 
biocompatibility) [8]. Scaffold production techniques can significantly affect their 
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characteristics, namely their porosity, degradation rate, as well as mechanical or chemical 
properties. Furthermore, there are procedures that prevent the use of cells and biologically 
active compounds due to the high temperatures or pressure values needed for their 
production [23]. 
Thus, the choice of the appropriate technique depends on the application and on the 
desired properties, taking into account that all of them have advantages and disadvantages. 
The most relevant scaffold fabrication technologies include [23]: 
 
1. Solvent casting/particulate leaching (SCPL), which is based on the 
dissolution of a material in an organic solvent, followed by the porogen 
addition, drying process and solidification, followed by porogen removal; 
2. Gas-foaming, in which CO2 is the porogen; 
3. Phase separation, which divides a homogeneous solution into two or more 
separate phases using a thermal treatment; 
4. Freeze-drying, where an emulsion is quickly cooled and then the water and 
other solvents are removed; 
5. Electrospinning, whose key-point is the application of high voltage to a 
polymeric solution and pumping it into a spinneret; 
6. Rapid prototyping, which combines computer and materials science in order 
to form a paste that later sets into a pre-defined shape; 
7.  Self-assembly, in which the components are autonomously organized 
without human intervention; 
8. Stereo-lithography, that uses UV laser power to harden a 
photopolymerizable material into a desired shape or pattern; 
9. Moulding techniques, in which a mould is filled with the material to give it 
a set shape. 
 
 
Some of the main advantages and downsides of each of these techniques are 
described in Table 4. 
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Table 4 – Advantages and disadvantages of some of the most common scaffold processing techniques 
(Adapted from [23]) 
Technique Advantages Disadvantages 
Solvent 
casting/particulate 
leaching 
Simple, inexpensive and allows 
control over porosity and pore 
size  
The use of toxic solvents and 
limitations in scaffold thickness 
Gas-foaming 
High porosity and organic 
solvent-free process 
Limited mechanical properties 
and low pore interconnectivity 
Phase separation 
Solvent-free technique, 
controlled porosity and can be 
used to produce nanofibers 
Difficult control of the scaffold 
micro- and macro-structure and 
limited material selection 
Freeze-drying 
Simple, solvent-free, high 
porosity and pore size control 
Slow process and low pore sizes 
Electrospinning 
Ability to produce fine fibres 
with special orientations and 
high surface area in a quick and 
simple way 
Mechanical properties limitations 
and difficulty in producing 
scaffolds with complex structures 
Rapid prototyping 
Highly accurate and 
reproducible method requiring 
minimal intervention and allows 
production of complex structures 
with controlled properties 
Expensive, often requiring high 
temperatures and organic solvents 
and limited material selection 
Self-assembly 
Toxic solvent-free process and 
allows producing nanofibers 
Expensive and limitations in 
terms of mechanical properties 
Stereo-lithography 
Allows the production of 
structures with complex internal 
features 
Limited selection of 
photopolymerizable materials 
Moulding techniques 
Solvent-free process providing 
independent control of porosity 
and pore size  
Difficulties in producing 
three-dimensional scaffolds, with 
risk of residual porogen, and high 
temperatures required 
 
  
Additive manufacturing (AM) techniques are processing technologies that have 
altered the way materials are designed, produced and distributed to end users, gaining 
significant interest in both academic and industrial environments. It is possible to find AM 
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techniques in different sectors, such as in the automotive and aerospace industries, in 
electronics, construction, medicine or even in the food industry. One feature that makes 
these techniques appealing is the ease to produce complex constructions with close to no 
residual materials, reducing waste [79]. 
Their ability to produce custom scaffolds makes these techniques interesting for 
biomedical applications, allowing the production of highly complex materials in a 
reproducible way. Some of these techniques include 3D printing, stereo-lithography and 
robocasting, and they are based on the assembly of three-dimensional structures 
layer-by-layer with the aid of a computer assisted design (CAD) model. An additional 
advantage of the use of these techniques is the possibility to use medical imaging data, 
such as X-ray or magnetic resonance imaging scans, to generate a CAD model that 
translates into a biomaterial that perfectly replicates the defect to repair [80]. 
 There are some examples of scaffolds for bone TE produced using this type of 
processing technique with promising results, recurring to materials such as HA, polylactic 
acid, polycaprolactone and some bioactive glasses [81]. However, production of pectin 
based biocomposites for tissue engineering via AM techniques is a field with much room 
for development, yet it would of great interest as a future final objective of this project. 
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Chapter 3 
Materials and Methods 
 
 
 
3.1 Materials 
 
The bioactive glass Di-70, whose molar composition is 38.48% SiO2, 36.52% CaO, 
19.24% MgO and 5.76% P2O5, was produced using high purity powders, as described in 
Table 5. 
 
Table 5 –Raw materials used to prepare bioactive glass. 
Material Brand Purity 
SiO2 Sibelco ≥99% 
CaCO3 Sigma-Aldrich ≥99% 
MgO Sigma-Aldrich ≥98% 
NH6PO4 Fluka ≥99% 
 
 
Low-methoxyl citrus pectin (Classic CU701) with a galacturonic acid unit content 
of 86% and a degree of methylation of 37% was provided by Herbstreith & Fox. 
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3.2 Glass synthesis and characterization 
 
Homogeneous mixtures of approximately 70 g batches of glass’s raw materials 
were obtained by ball milling for about 10 minutes. Afterwards, the mixture was 
transferred to alumina crucibles for calcination at 900ºC for 1 hour (2ºC/min rate), after 
which the material was melted in platinum crucibles for 1 hour at 1570ºC (10ºC/min rate). 
The glasses were obtained in frit form by quenching the melted glass in cold water. The 
glass frits were dried in a drying oven at 100ºC for 24 hours prior to being milled in 
planetary agate ball mill for 2 hours at a speed of 200 rpm (Retsch PM 400). 
After that, the resulting fine glass particles were sieved (<500 μm) and their mean 
size (φ) was determined by a light scattering technique (Coulter LS230, Beckman Coulter; 
Fraunhofer optical model), being of about 8 μm. Part of the obtained glass particles was 
stored in a desiccator and the other part was submitted to a wet ball milling process to 
further decrease mean particle size. The glass powders were milled in ethanol for about 18 
hours at a speed of 750 rpm in an attrition mill. These powders with mean particle size of 1 
μm were then dried for 24 hours at 100ºC, sieved again (<40 μm) to eliminate 
agglomerates and stored in a desiccator until further use. 
The amorphous/crystalline nature of the glass frits was analysed by X-ray 
diffraction (XRD) analysis (Rigaku Geigerflex D/Max, Tokyo, Kapan; C Series, CuKα 
radiation; 2α angle range: 10º–80º; step of 0.02º/s). 
 
 
3.3 Pectin purification and biofunctionalization 
 
Prior to any studies or modifications, pectin was purified to reduce common 
contaminants such as proteins, polyphenols and endotoxins [51]. Succinctly, a 1% (w/v) 
pectin solution was prepared by dissolution of the polymer in HyClone™ endotoxin-free 
cell culture grade water (GE Healthcare) and its pH was adjusted to 6 using NaOH (1M 
and 5M, Merck) solutions. Then, the solution was sequentially filtered with 0.80 μm, 0.45 
μm and 0.22 μm mixed cellulose ester filter membranes (Millipore). After filtering, 2% 
(w/v) of activated charcoal (Sigma) was added to the solution and the mixture was agitated 
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for 1 hour at 250 rpm in an orbital shaker oven (IKA® KS 4000 ic control) at room 
temperature. Afterwards, the suspension was centrifuged at 60 000 g for 1 hour at 20ºC 
(Beckman Avanti J-26 XP, Beckman Coulter), the supernatant was carefully decanted and 
ultracentrifuged at 120 000 g for 1 hour at 20ºC (Beckman Optima L80-XP, Beckman 
Coulter). Finally, the supernatant was retrieved and filtered once more with 0.22 μm filter 
membranes, frozen at –20ºC, freeze-dried for 3 days (BenchTop Pro, VirTis) and stored at 
–20ºC until further use. 
After the purification process was complete, pectin was functionalized by covalent 
grafting of the oligopeptidic sequence (glycine)4-arginine-glycine-aspartic acid-serine-
proline (G4RGDSP, Genscript). The reaction was carried out by an adapted method of 
aqueous carbodiimide chemistry (Figure 6) [51, 62, 82]. Briefly, a 1% (w/v) solution of 
purified pectin was prepared in a 0.1 M 2-(N-morpholino) ethanesulfonic acid (MES) 
buffer solution (0.1 M MES buffering salt, 0.3 M NaCl, pH adjustment to 6 using a 1 M 
NaOH solution, Sigma) in ultrapure water. The solution was divided in two: the pectin to 
be functionalized (RGDpec) and the control (BLKpec). N-Hydroxy-sulfosuccinimide 
(sulfo-NHS, Aldrich) and 1-ethyl-(dimethylaminopropryl)-carbodiimide (EDC, Sigma, 
59.65 mg per g pectin) at a molar ratio of 1:2 were added quickly and in this sequence to 
both solutions. The peptide was also rapidly added only to the RGDpec solution (50 mg 
per g pectin). The solutions were allowed to react for 20 hours at room temperature while 
stirring, and were then quenched with hydroxylamine hydrochloride (18 mg per g pectin, 
Sigma). Afterwards, both polymer solutions were dialyzed (MWCO 3500, Spectra/Por®, 
SpectrumLabs) against decreasing concentrations of NaCl solutions in deionized water (7.5 
to 0 g/L) for 3 days, with solution renewal 3 times a day. Next, activated charcoal (2 wt%) 
was added to both solutions, they were stirred for 1 hour and ultracentrifuged twice as 
previously described. Once more, both solutions were filtered through 0.22 μm filter 
membranes (Steriflip® filter unit, Millipore), frozen, lyophilized and stored at –20ºC until 
further use. 
The effectiveness of the RGD coupling to the purified pectin was assessed by a UV 
absorbance assay (200–260 nm region) against BLKpec using a 384-well UV transparent 
microplate (Greiner) in a micro-plate reader (PowerWave XS, BioTek). A calibration 
curve (Annex I) was prepared with a series of 1 wt % BLKpec with increasing RGD 
concentrations, which served as standard to determine the extent of the RGD grafting. 
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Figure 6 – Schematic representation of pectin grafting with the RGD-containing peptide [Adapted from 
[62]). 
 
 
3.4 Preparation of hydrogel-bioactive glass composites 
 
In situ crosslinking composite hydrogels were prepared adapting the internal 
gelation method described in the group’s past studies that relies on the calcium 
carbonate/D-glucono-δ-lactone (CaCO3/GDL) slow gelling system. In this method, GDL 
hydrolyses with time, lowering the pH of the mixture, which triggers the slow release of 
calcium from CaCO3, promoting the formation of the egg-boxes, as previously described. 
To determine the quantities of both CaCO3 and GDL, the stoichiometric ratio of Ca2+-to-
COO– groups was determined according to Eq. 1, and the amount of GDL needed for the 
number of Ca2+ without severely affecting the pH of the solution was calculated using Eq. 
2 [51]. The COO– groups of the pectin were estimated from its DM. 
 
R = 2[Ca2+]/[COO–]      (1) 
RCa-GDL = 2[Ca2+]/[GDL]     (2) 
 
In the present work, however, the calcium carbonate was completely replaced with 
the bioactive glass particles (both 1 μm and 8 μm) and gels were produced with and 
without GDL. For the preparation of hydrogels, 3% (w/v) pectin solutions were prepared in 
0.9 wt % NaCl (VWR) in deionized water. Afterwards, an aqueous suspension of the 
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bioactive glass was carefully dispersed into the polymeric solution and either a freshly 
made GDL (Sigma) solution or its respective volume in 0.9 wt % NaCl was added to the 
mixture. The R and RCa-GDL ratios were kept constant throughout the experimental work 
(R=1 and RCa-GDL=0.5, to ensure an excess of calcium, in order to increase the probability 
of saturating the egg-box zones) [51]. A set amount of the gel-precursor solution was 
transferred to a polytetrafluoroethylene (PTFE) surface inside a petri dish and compressed 
with another PTFE plate, and gel height was set using 1 mm spacers (Figure 7). The 
environment was kept humidified by adding deionized water to the bottom part of the petri 
dish and covering it, and the solutions were left to gel on their own for different amounts of 
time depending on their formulation. 
 
 
 
Figure 7 – Hydrogel production scheme: a) Gel-precursor solution was pipetted into a PTFE plate; b) the 
gels were compressed with another PTFE plate and left to gel. 
 
 
 
Different hydrogel formulations were tested, varying Di-70 particle size, bioactive 
glass content and pectin concentrations. Those are described in Table 6. Only one 
formulation using GDL was tested. 
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Table 6 – Tested hydrogel formulations. 
Formulation 
Pectin % 
(w/v) 
Di-70 φ 
(μm) 
Di-70 Concentration 
(mg/mL) 
GDL Concentration 
(mg/mL) 
A 
1.5 
8 2.34* - 
B 
1 and 8 
(50% each) 
2.34* - 
C 
1 
4.67 - 
D 2.34* - 
E 1.17 - 
F 2.34* 8.32 
G 1 1.56* - 
*This bioactive glass content corresponds to the calcium carbonate concentration of the protocol for R=1 and 
RCa-GDL=0.5 and will hereafter be referred to as BG1. The other bioactive glass concentrations are either 
doubled (BG2) or halved (BG0.5). 
 
 
3.5 Rheological characterization of the composite hydrogels 
 
The rheological behaviour of the hydrogels and gel-precursor solutions was 
assessed using a Kinexus Pro rheometer (Malvern Instruments). Hydrogel disks were 
prepared from 40 μL of gel-precursor solution as previously described and incubated in 
24-well plates at 37ºC. Initial tests were performed in gels that were incubated in 500 μL of 
water for 24 hours and, later on, some formulations were tested after incubation in 500 μL 
Dulbecco’s modified eagle medium-Hepes (DMEM-HEPES, Gibco) for 1 and 3 days. For 
the selection of a formulation for further studies, the effect of adding 10% v/v fetal bovine 
serum (FBS, Gibco) to the medium was assessed. 
The rheological tests were carried out at 37ºC in a water-vapour saturated 
environment ensured by the rheometer chamber. Gels were punched into cylinders (with 4 
mm biopsy punch cylinders) and oscillatory measurements were performed using parallel 
plate geometries, compressing the gels by 20% of their height, iteratively performing 
frequency and amplitude sweep measurements in order to determine the gels’ linear 
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viscoelastic region (LVR) (Figure 8). The viscoelastic properties of hydrogel solutions 
overtime were assessed using frequency and shear strain values within each formulation’s 
LVR. 
 
 
 
Figure 8 – Examples of elastic component (G’) of the shear modulus values obtained in frequency and 
amplitude sweeps for the determination of the LVR (D formulation after 24h incubation in DMEM -HEPES). 
 
 
3.6 Measurement of swelling profiles 
 
To study the swelling profiles of the composite hydrogels, a final pectin 
concentration of 1.5% was set for five different formulations without GDL (formulations A 
through E, n = 4 for each formulation). Hydrogels prepared from 20 μL gel-precursor 
solution were produced as described in section 3.4, and were incubated for 24 and 72 hours 
in 500 μL DMEM-HEPES at 37ºC. For each time point, gels were weighed (W1), frozen 
and freeze-dried. After the lyophilisation was complete, gels were weighed again (W2) and 
the swelling ratio (SR) was calculated using the following equation: 
 
SR = W1 / W2      (3) 
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3.7 In vitro stability studies 
 
In order to assess the composite’s stability in cell culture medium, 20 μL hydrogels 
(D formulation) were incubated in the same conditions later used for cell culture studies 
with mesenchymal stem cells, i.e., at 37ºC with minimum essential medium α (α-MEM, 
Gibco) supplemented with 10% v/v inactivated FBS and 1% v/v penicillin/streptomycin 
(P/S, Biowest) (complete α-MEM). Medium samples were retrieved after 1, 24 and 72 
hours of incubation and complete medium that had not been in contact with the materials 
was used as a control. Samples were treated with 0.1% v/v nitric acid (65%, Merck) and 
stored at 4ºC until spectrophotometric analysis was performed to investigate the changes in 
medium composition. The investigated ions were the ones present in the bioactive glass 
composition (calcium, magnesium, silicon and phosphate), and absorbance values were 
measured. Calcium and magnesium were measured using flame atomic absorption 
spectroscopy (Perkin-Elmer, Aanalyst 200) and silicon and phosphate were measured 
using standard colorimetric methods with absorbance spectroscopy in the visible spectral 
region (Jenway 6100). Samples were read in triplicates and final concentration values were 
calculated with the aid of a calibration curve for each element (Annex II). 
 
 
3.8 In vitro assessment of metabolic activity and cytotoxicity  
 
In order to pre-screen metabolic activity and cytotoxicity of the hydrogel-bioactive 
glass composites prepared human dermal neonatal fibroblasts (hDNFs) isolated from 
foreskins of healthy male newborns (Zenbio) were used. hDNFs were cultured in DMEM 
supplemented with 10% v/v FBS (Gibco), 1% v/v P/S (Biowest) and 1% v/v amphotericin 
B (Capricorn Scientific) (complete DMEM). Cells were maintained at 37ºC in a humidified 
atmosphere of 5% CO2 and at 80-90% confluence fibroblasts were trypsinized (0.05 wt% 
trypsin/EDTA solution). Cells from passage 6 were used in this study.  
To determine the effect of the composite hydrogels, a cytotoxicity assay was 
performed using hDNFs according to ISO 10993-5 standard practice. For this test, cells 
were trypsinized at pre-confluence and centrifuged. After discarding the supernatant, 2104 
cells were seeded into 24-well plates and incubated in complete DMEM in a humidified 
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atmosphere of 5% CO2 at 37ºC. Simultaneously, 20 μL hydrogels (D formulation – 1.5% 
pectin, 1 μm glass particles, BG1 content) were incubated under the same conditions. After 
24 hours of incubation, both a direct contact and indirect contact test were performed 
(n=3). For the direct contact assay, samples were directly put into the wells containing 
fibroblasts and the medium was refreshed. For the indirect contact assay, the medium was 
replaced by the medium that had been incubated with the hydrogels for 24 hours. As a 
control, wells with fibroblasts that were not in contact with the materials were used. The 
results were obtained through a resazurin-based assay. Briefly, culture medium was 
removed and replaced with 500 μL complete medium with 20% v/v resazurin (Sigma) and 
the 24-well plates were incubated for two hours at 37ºC in a humidified incubator with 5% 
CO2. Then, 100 μL from each well were transferred to wells of a black 96-well plate and 
fluorescence was measured (λex = 530 nm, λem = 590 nm) using a micro-plate reader 
(Synergy MX, BioTek). 
For the pre-screening of cell entrapment, hDNFs were loaded within composite 
hydrogels. hDNFs were trypsinized before reaching confluence and centrifuged. The 
supernatant was discarded, cells were carefully added to the gel-precursor solution (107 
cells/mL) and gels were produced from 20 μL of this solution, as previously described. For 
completion of gelling, samples were placed in an incubator (37ºC, 5% CO2 humidified 
atmosphere) for about 1 hour. After that, gels were placed in 24-well plates and complete 
DMEM was added. After 24 hours, the culture medium was replaced once more. At days 1 
and 7 of culture, cell metabolic activity was measured as described in the section below. 
For this assay, two hydrogel formulations were produced (C and D, both having a final 
pectin concentration of 1.5% and 1 μm glass particles, but with different Di-70 contents, 
BG2 and BG1 respectively). Two different pectins were also tested: RGDpec (with a final 
RGD density of 200 μM) and BLKpec as a control. Cell metabolic activity at different 
timepoints was evaluated using a resazurin-based assay as previously described. 
Cell morphology was investigated for entrapped hDNFs after 1 and 7 days. 
Fibroblast-loaded hydrogels were washed with phosphate-buffered saline (PBS), fixed for 
20 minutes in 4% PFA/PBS and stained for filamentous actin (F-actin) and nuclei. Briefly, 
after fixation and rinsing, samples were permeabilized with 0.1% Triton X-100 (Sigma) in 
PBS for 5 minutes. They were then incubated for 30 minutes with 1% bovine serum 
albumin (BSA, Merck) in PBS. For F-actin staining, samples were incubated with the 
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conjugated probe phalloidin/alexa fluor® 488 (Molecular Probes-Invitrogen, 1:40 in 1% 
BSA) for 1 hour at room temperature. Finally, samples were washed three times with PBS 
and nuclei were counterstained with 4’,6-diamidino-2-phenylindole dihydrochloride 
(DAPI, H-1200, Vector) just before confocal visualization (CLSM, Leica SP2AOBS, Leica 
Microsystems) using LCS software (Leica Microsystems). The scanned Z-series were 
projected onto a single plane and pseudo-coloured using ImageJ. 
 
 
3.9 Biological behaviour of mesenchymal stem cells embedded 
within composites  
 
The biological behaviour of the prepared composites was assessed using embedded 
therapeutically relevant cells for orthopaedic applications. Human mesenchymal stem cells 
(hMSCs) isolated from bone marrow (Lonza) were cultured in α-MEM supplemented with 
10% v/v inactivated FBS (Gibco) and 1% v/v P/S (Biowest) (complete α-MEM) at 37ºC in 
a humidified atmosphere of CO2. Cell culture medium was changed every 2–3 days, and 
cells were trypsinized (TrypLE™) at pre-confluence. For this study, cells were used in 
passage 12. 
The production of cell-embedded gels with hMSCs was similar to the procedure 
described for fibroblast entrapment, although cell density used in the present case was 
8106 cells/mL and complete α-MEM was used instead of DMEM. The medium was 
changed every 2–3 days. To induce the differentiation of hMSCs along the osteoblastic 
lineage, hydrogels were also incubated with osteogenic medium: basal medium 
supplemented with 100 nM dexamethasone (Sigma-Aldrich), 10 mM β-glycerophosphate 
(Sigma-Aldrich) and 0.05 mM 2-phospho-L-ascorbic acid (Fluka). Cell-laden hydrogels 
were kept in culture for up to 21 days and a single formulation was tested (D), both with 
RGDpec and BLKpec as described above. 20 μL samples were used to assess cell 
metabolic activity, morphology and differentiation and 40 μL samples were used to 
evaluate their rheological properties. Rheological analysis of composites with embedded 
cells was performed in samples after 1 and 14 days in culture using both basal and 
osteogenic media. Shear moduli component values were averaged from amplitude and 
frequency sweeps within the LVR. 
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To assess the differentiation of hMSCs embedded into the composite, a Von Kossa 
staining assay was performed. Samples from days 7 and 21 of culture were washed in Tris-
buffered saline (TBS) and cells were fixed with 4% PFA/TBS for 20 minutes. Afterwards, 
samples were incubated for 30 minutes under UV light in 500 μL of a 2.5% (w/v) silver 
nitrate solution. Then, the materials were rinsed with deionized water and incubated in 500 
μL of sodium thiosulfate 5% (w/v) for 3 minutes at room temperature. After rinsing with 
deionized water once more, samples were observed under a stereomicroscope (Olympus 
SZX9). 
Cell morphology was also investigated for hMSCs (time-points: day 1 and 21). 
Mesenchymal stem cell-loaded hydrogels were washed with TBS, fixed in 4% PFA/TBS, 
and finally stained for filamentous actin and nuclei, similarly to the procedure previously 
described, but using TBS instead of PBS. The visualization and image processing 
procedures were performed as described in section 3.8. 
 
 
3.10 Statistical analysis 
 
Statistical analyses were performed using GraphPad Prism 7.02 software. Data was 
analysed using the non-parametric Mann–Whitney test. All tests were performed using a 
95% confidence interval and statistically significant differences are marked with either 
different symbols between parameters or with a * (p < 0.05). Some statistical data is 
presented in Annexes III and IV in table format in order to increase correspondent figure 
readability. 
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Chapter 4 
Results and Discussion 
 
4.1 Bioactive glass characterization 
 
4.1.1 Crystallographic characterization 
 
The X-ray diffraction spectrum of the bioactive glass frits is presented in Figure 9. 
It was possible to confirm the amorphous structure of the glass due to the absence of 
crystalline phases. 
 
 
Figure 9 – XRD spectrum of the Di-70 glass frits. 
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4.1.2 Particle size distribution 
 
Given that the particle size of the reinforcing component (bioactive glass) greatly 
influences the composite’s mechanical and biological properties [72-74], and since the 
study of those effects was one of the objectives of this work, bioactive glass particle size 
distribution was assessed. As previously described, after drying the glass frits, they were 
submitted to a planetary milling process, which allowed obtaining particles with a mean 
size of approximately 8 μm. Afterwards, in order to achieve smaller particle sizes, glass 
powder was wet milled for several hours, and the evolution of the process is showed in 
Figure 10. 
 
Figure 10 – Bioactive glass particle size evolution throughout the wet ball milling process. The 0h line 
corresponds to particle size distribution after the planetary milling process for 2 hours. 
 
After just 3 hours of wet milling, mean particle size was decreased to 1.8 μm and 
after 12 hours particle mean size reached 1.2 μm. However, the particle size distribution 
graph in Figure 10 indicates that, even though mean particle size was 1.2 μm, particles 
were not evenly distributed, possibly due to aggregation, despite the fact that light 
scattering tests were performed after ultrasonic agitation and using a dispersant (Targon 
1128) to reduce attraction forces between the particles [83]. However, increasing mill time 
to 18 hours allowed the obtention of evenly distributed particles, whose mean size was 
approximately the desired 1 μm. 
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4.2 Pectin characterization 
 
Plant-extracted polymers usually have some content of contaminants such as 
proteins, polyphenols and endotoxins, which is why a purification process is necessary 
before preparing a material for biomedical applications. Despite its great interest for tissue 
engineering applications, pectin is not commercially available in medical grade purity. 
Previous studies from the group report that a purification protocol close to the one used in 
this work lead to a 70% decrease in protein content, 52% in polyphenols content and 96% 
in endotoxin levels [51]. The efficiency of the purification method used in this work was 
calculated taking into consideration the initial mass of raw pectin and the final mass of 
purified pectin, and resulted in a yield of 71%. 
After purification, pectin was functionalized with an RGD containing peptide and 
the UV spectrum of RGDpec showed the presence of a characteristic peak around 230 nm, 
which indicated effective peptide grafting to the polymer. With the aid of a calibration 
curve (Annex I) produced from the analysis of several spectra of pectin solutions 
containing different known RGD concentrations (Figure 11), the quantity of RGD 
successfully grafted into the polymer was estimated to be of 22 mg per g of pectin. 
 
 
Figure 11 – UV spectrum of RGDpec and Blank pectin solutions containing different RGD concentrations. 
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4.3 Physico-chemical characterization of composites 
 
4.3.1 Rheological characterization  
 
Initial rheological tests were performed to samples incubated in water for 24 hours 
at 37 ºC to provide a preliminary evaluation of the materials properties and their gelation 
profiles. Five formulations containing the standard BG1 glass concentration were tested: 
A, B, D, F and G. The first four samples correspond to 1.5% pectin gels, being A with 8 
μm glass particles, B with a mixture of 8 and 1 μm particles, D with 1 μm particles without 
GDL, F being similar to D but using GDL, and finally G being similar to D with a lower 
pectin concentration (1%).  
The linear viscoelastic region for each formulation was determined, shear moduli 
components values were obtained (Figure 12) and gelation tests were performed (Table 
7). The gelation profile of hydrogels was used to evaluate the time necessary for gels to 
present a solid-like behaviour. Gelation was considered to be triggered when there was a 
crossover between the elastic (G’) and viscous (G’’) components of the shear modulus 
(i.e., the time at which the phase angle, δ, goes below 45º), and it was decided that gels 
exhibited a solid-like behaviour when the phase angle went below 10º [51] (Figure 13). 
 
Figure 12 – Shear modulus - elastic component (G’) - values for the preliminary scanning of the different 
composite formulations in water (37ºC). Different symbols denote statistically significant differences between 
G’ values of different formulations (p<0.05, n=4). 
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Figure 13 – Gelation test performed to sample of formulation D. Phase angle dropped below 45º after 
approximately 25 minutes, and below 10º after 30 minutes. The test was carried at constant 0.1 Hz and with 
1% constant strain (LVR). 
 
Table 7 – Gelation profiles of the composites. 
Formulation 
Gelation triggering time 
(δ <45º) (min) 
Solid-like behaviour 
(δ <10º) (min) 
A 80 95 
B 33 40 
D 25 30 
F 1 1.5 
G 35 40 
 
 
Rheological analysis revealed that the bioactive glass-reinforced pectin-based 
composites prepared are able to form hydrogels without adding GDL for pectin 
crosslinking, within clinically relevant time frames. The addition of GDL creates an 
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additional unnecessary stress for cells when their entrapment is envisioned due to its pH 
lowering effect, and increases hydrogel production complexity [6]. 
Rheometry results showed that composites with finer glass particles had higher 
shear modulus values and lower gelation times. A, B and D formulations differ only in 
glass particle size, and D (with only 1 μm particles) clearly showed higher G’ values. As 
polymer concentration decreased to 1% (formulation G, which had the same glass 
concentration and particle size as D), an evident decrease in elastic component value was 
observed, as well as a slight increase in gelation times. Neves et al. (2015) reported similar 
results, where 1.5% pectin hydrogels produced by internal gelation presented lower G’ 
values and longer gelation times when compared to 2.5% pectin hydrogels [51]. 
Regarding gelation times, formulation A took the longest time to stiffen, and this 
formulation was discarded from further tests since 95 minutes for gelation was considered 
an inadequate amount of time for cell survival in a potential embedding process. The 
addition of GDL (formulation F) proved to hasten the gelation, although its shear modulus 
values varied too quickly, which could also lead to increased cell stress. Since it was 
shown that these composites can form hydrogels without GDL within clinically acceptable 
timeframes, this component was not included in further tests.  
The effect of bioactive glass concentration was also assessed. Formulations C and 
E (BG2 and BG0.5 concentrations, respectively) were compared to the previously analysed 
formulation D (BG1 concentration). For these tests, instead of using water, samples were 
incubated in DMEM-HEPES at 37ºC to provide more meaningful biological significance, 
and rheological tests were performed after 1 and 3 days of incubation to evaluate the 
material’s properties overtime (Figure 14). 
 
  
 
Manuel João Barros  Chapter 4 – Results and Discussion 
 
45 
 
 
 
Figure 14 – Shear modulus - elastic component (G’) - values of formulations varying in Di-70 content after 
incubation at 37ºC in DMEM-HEPES for up to 3 days (pectin concentration kept constant at 1.5% and glass 
particle size of 1 μm). Different symbols denote statistically significant differences between G’ values of 
different formulations and timepoints (p<0.05, n=4). 
 
Results from Figure 14 show that the reinforcement content also had a significant 
effect in the composite’s properties. The incubation medium influenced the properties of 
the hydrogels since, after 24 hours, D samples incubated in DMEM-HEPES exhibited a 
much higher G’ value than comparable samples incubated in water (4590 Pa in 
DMEM-HEPES vs. 2950 Pa in water). It is also shown that shear modulus values also tend 
to increase with time, as evidenced for every tested formulation. These effects could be 
related to the presence of calcium in the medium’s composition (under the form of calcium 
chloride, according to the manufacturer), which could potentiate the crosslinking of pectin 
overtime. As expected, higher glass concentrations also translated into higher G’ values 
due to higher cation content. Gelation times were also affected by the presence of different 
quantities of Di-70, as gels took longer to form with lower glass concentrations (C: 
tδ<45º=20 min, tδ<10º=25 min; D: tδ<45º=25 min, tδ<10º=30 min; E: tδ<45º=75 min, tδ<10º=105 
min). The E formulation, which had the lowest amount of bioactive glass (BG0.5), and 
similarly to the previously analysed formulation A, presented a very long gelation time, 
unsuitable for the embedding of cells. Formulation C, although with a similar gelation time 
to D, displayed a much higher variation in G’ values overtime, which could also inhibit 
maintenance of cell viability due to impacts on their ability to adhere and proliferate [84]. 
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Hence, formulation D yielded the most appealing properties in terms of shear 
modulus values and gelation times and, as such, an additional rheological characterization 
assay was performed in order to evaluate the effects of adding FBS to the incubation 
medium (Figure 15). LVR studies were once more carried out for D samples that had been 
incubated for 1 and 3 days at 37ºC, this time in DMEM-HEPES supplemented with 10% 
v/v FBS. These results showed an increase in G’ values after both 24 and 72 hours, even 
though differences weren’t statistically significant at day 3. This effect could once more be 
related to the presence of additional crosslinking agents in the medium influenced by the 
FBS, as Vetsch et al. (2015) reported the appearance of calcium deposits on the surface of 
scaffolds cultured with some types of serum, even in acellular conditions [85]. 
 
 
Figure 15 – Shear modulus - elastic component (G’) - values of formulation D hydrogels incubated with and 
without 10% FBS at 37ºC for up to 3. Different symbols denote statistically significant differences between 
G’ values of samples from different incubation media and timepoints (p<0.05, n=4). 
 
 
4.3.2 Swelling profiles  
 
For the study of the swelling profiles of the hydrogel composites, formulations 
containing a constant pectin concentration of 1.5% and variable glass content in terms of 
concentration and particle size (formulations A, B, C, D and E) were incubated in 
DMEM-HEPES for up to 72 hours (Figure 16). 
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From the analysis of Figure 16, it is possible to infer that the first 24 hours were 
the most important for the swelling of composites. In these first 24 hours, formulations 
containing only finer glass particles (D and E) showed similar and higher swelling ratios 
when compared to the other formulations. However, the swelling ratio of formulation D 
remained stable between 24 and 72 hours, while the swelling ratio of formulation E 
decreased with time. This makes Formulation D more attractive for cell entrapment, since 
it provides a more stable environment for cell proliferation sooner than other compositions. 
Formulation C, even though it was also produced with 1 μm glass particles, presented very 
different results, having the lowest ratio at 24 hours and the highest after 72 hours, 
suggesting that a higher glass content (BG2) significantly interferes with the hydrogel 
matrix. This was an unexpected result, as literature suggests that higher glass contents 
result in lower swelling percentages and water uptakes due to the glass particles occupying 
the free voids within the polymeric matrix [65, 70].  It should also be noted that even after 
72 hours, formulation C still had not achieved swelling equilibrium. 
 
Figure 16 – Swelling profiles of A, B, C, D and E formulations of composites. Higher bioactive glass content 
(C) translated in a higher swelling ratio with time. Mixture of two particle sizes seems to significantly change 
the swelling profile of the hydrogels. Legend: * mark denotes statistically significant differences between 
swelling ratios of different formulations and timepoints (p<0.05, n=4). 
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Gels containing 8 μm glass particles (A and B) presented similar swelling ratios at 
time-point 24 hours, yet their behaviour changed with increasing incubation time. After 
incubation for 72 hours, the hydrogel with mixed glass particle sizes (B) seemed to retract 
the most out of the studied samples, having the lowest swelling ratio at that time-point. 
Comparing formulations A and D, which contained similar glass content but 8 μm and 1 
μm glass particles respectively, exhibited expected swelling profiles, with composites with 
finer glass particles presenting higher swelling ratios, which could be related to the higher 
surface area and higher extent of exposure of the 1 μm particles on the material’s surface 
[73]. 
Retrieving samples from an earlier timepoint than 24 hour time period could be 
interesting in future work in order to understand what happens in the first few moments of 
immersion and when the most critical alterations occur. Longer incubation times could also 
provide relevant information regarding equilibrium swelling rates. 
One additional detail that was noticeable for formulation C was that after 72h in 
DMEM-HEPES, some turbidity was detected, which could be related to an initial diffusion 
of excess glass particles into the medium followed by some kind of precipitation. For that 
reason, changes to the medium’s composition were analysed. 
 
 
 
4.3.3 In vitro stability in cell culture medium 
 
In order to analyse the stability of the prepared composites in cell culture medium, 
changes in cell culture medium induced by the presence of the composites were assessed. 
Composites (D formulation) were incubated in complete α-MEM and the concentration of 
ions in the medium was assessed over time, as presented in Figure 17. 
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Figure 17 – Alterations in concentration of bioactive glass components in cell culture medium after 1, 24 
and 72 hours immersion of composites. 
 
Analysis of Figure 17 indicates that the composites had, indeed, influence in the 
chemical stability of cell culture medium. Figures 17 shows a decrease in medium 
concentration of calcium and phosphate (as determined by spectrophotometric analysis) 
which may be related to the formation of calcium phosphate (such as hydroxyapatite) 
deposits on the material, and which could be further investigated with surface or bulk 
analysis of the material (for instance, XRD and Fourier transform infrared spectroscopy 
(FTIR) analysis) [69, 73]. Additionally, calcium concentration could be decreasing due to 
further reticulation of pectin, congruent with the increase of G’ values of gels incubated in 
cell culture medium. 
For the remaining ions (silicon and magnesium), a clear increase in both elements’ 
concentrations was noticeable in the first hour of contact with the samples, which may be 
due to the initial dissolution of these components into the medium, considering Di-70’s 
high content of both SiO2 and MgO. However, in the following 24 hours these medium 
concentrations started to decrease, possibly due to a recrystallization of the particles.  
Magnesium’s levels tended to stabilize to initial values, but silicon content dropped below 
the initial medium concentrations, which is in agreement with Hench’s model for in vitro 
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effects of bioactive materials, due to the establishment of a silicon-rich layer at the 
material’s surface [45, 47]. Further studies on this topic could help better characterize the 
composite’s effect on cell culture medium and how it influences cell growth, proliferation 
and viability. 
 
 
4.4 In vitro assessment of metabolic activity and cytotoxicity  
 
The cytotoxicity of the composite hydrogels was evaluated using direct and indirect 
contact tests, according to ISO 10993-5 standard practice. Formulation D was the one 
selected for this assay due to the previously presented favourable characteristics, namely 
its more stable rheological properties and swelling profile, as well as interesting in vitro 
effect on cell culture medium, making it suitable for tests with cells. Indeed, the materials 
were proved to be non-cytotoxic to cultured fibroblasts, as both direct and indirect contact 
assay results showed cell metabolic activity values above 70% of the controls’ measured 
values (Figure 18). 
 
Figure 18 – Metabolic cell activity normalized for cell number for each assay of the cytotoxicity test. Both 
Indirect contact and direct contact tests show positive results. Legend: * mark denotes statistically 
significant differences between measured metabolic activity of tests comparing to the control  (p<0.05, n=3). 
 
The positive results of this initial scanning assay allowed the next step of the work 
to be performed consisting in the embedding of cells into the composite’s matrix, which 
increases the material’s likelihood of being used as a cell delivery system in tissue 
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engineering and regenerative medicine applications. At this stage of the work, fibroblasts 
were used instead of mesenchymal stem cells due to being easier to culture and having 
higher proliferative rates, making them more appropriate for the pre-screening and 
optimization processes. 
Cell metabolic activity of the hDNFs embedded within the composite matrices was 
measured after 1 and 7 days in culture with a resazurin assay (Figure 19). Formulations C 
and D were tested in this assay, as well as both BLKpec and RGDpec. Statistical analysis 
results can be found on Annex III. 
 
 
Figure 19 – Metabolic activity of hDNFs embedded in composite hydrogels (formulations C and D, both with 
BLKpec and RGDpec) after 1 and 7 days of culture. Statistical analyses were performed to compare each 
formulation through every time-point and different formulations within the same time-point. 
 
At day 1 of culture, no statistically significant differences could be noted between 
the formulations, although both BLKpec and RGDpec of formulation D showed higher 
values than those of formulations C. At day 7, however still metabolically active, cells 
embedded in all different composites exhibited lower metabolic activity values comparing 
to day 1. This behaviour has already been reported for hydrogels containing embedded 
fibroblasts and it was linked to the contraction of the hydrogel’s matrix after long culture 
time periods [86]. Moreover, this decrease in metabolic activity could be associated with 
the composite’s released ions, although additional studies on this topic would be required 
in order to confirm if their effect is indeed detrimental for fibroblast viability. Nonetheless, 
RGDpec displayed better results than BLKpec, as expected due to the peptide’s ability to 
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promote cell anchorage and the establishment of inter-cellular networks [51]. This was 
particularly notable in formulation C’s results, which presented statistically significant 
differences between BLKpec and RGDpec at day 7. 
The morphology of embedded hDNFs was assessed by labelling their actin 
filaments and nuclei and analysing by confocal microscopy. Samples were washed and 
fixed using PBS, which degraded the hydrogels containing lower bioactive glass 
concentrations, that being the reason why only projections of C formulations are presented 
in Figure 20. 
 
Figure 20 – Morphology and spatial arrangement of human dermal neonatal fibroblasts embedded within 
composite hydrogels (C formulation) after 1 and 7 days of culture, stained for F-actin (green) and nuclei 
(blue) (scale bars: 100 μm). 
 
Depending on the matrix in which they were embedded, fibroblasts presented 
different morphologies and spatial organisation. A great difference is noticeable after 7 
days in culture, where RGDpec provided a matrix suitable for cell spreading, as it is 
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possible to see cell-to-cell contact points. On the contrary, cells embedded in BLKpec 
presented a round shape, which is not typical for fibroblasts. Another interesting 
observation is that, in RGDpec, dividing cells can be observed, proving that even though 
they were exposed to high stiffness values, the composite mesh allowed fibroblasts to grow 
and proliferate. 
 
 
4.5 Biological behaviour of mesenchymal stem cells embedded within 
composites  
 
After the pre-screening and optimization processes, further tests were carried out 
using therapeutically relevant cells for orthopaedic applications, i.e. mesenchymal stem 
cells, with the selected formulation D composites, due to their previously proved 
interesting mechanical and biological properties. Cell metabolic activity of the hMSCs 
embedded within the composite matrices was measured after 1, 14 and 21 days in culture 
under basal and osteogenic conditions with a resazurin assay (Figure 21). Hydrogels using 
D formulation were tested in this assay, as well as both BLKpec and RGDpec. Statistical 
analysis results can be found on Annex IV. 
 
Figure 21 – Metabolic activity of hMSCs embedded in composite hydrogels (Formulation D, both with 
BLKpec and RGDpec) after 1, 14 and 21 days of culture in basal or osteogenic medium. Statistical analyses 
were performed to compare each formulation through every time-point and different formulations within the 
same time-point. 
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The graph in Figure 21 shows that a slight decrease in metabolic activity was 
observed throughout the whole experience for all samples, similarly to what happened with 
the fibroblast-laden hydrogels. In this case, however, the decrease was much less 
significant. At day 1, every sample presented similar results with the exception of cells in 
composites produced with RGDpec and cultured under osteogenic conditions, which 
showed slightly lower values. At day 14, all four conditions presented a slight decrease in 
cell metabolic activity, with formulations using BLKpec not exhibiting statistically 
significant differences. Additionally, metabolic activity for cells in basal medium was 
noticeably higher than that of cells in osteogenic medium. After 21 days in culture, while 
metabolic activity for cells under basal conditions mostly remained stable and higher than 
in osteogenic conditions, there was a small increase in hMSCs’ activity in an osteogenic 
medium. Overall, cells remained viable during the full duration of the assay and their 
metabolic activity was slightly higher for the basal media conditions. Previous studies 
testing the viability and differentiation of hMSCs seeded on the bioactive glass used in this 
work (Di-70) showed similar metabolic activity results to the ones obtained here, with cells 
under basal conditions presenting higher fluorescence values than those cultured in 
osteogenic medium at 14 days of culture [49]. Nonetheless, this composite provided a 
favourable environment to maintain cell viability without the need to add osteogenic 
supplements, possibly due to the release of ions that influence cell behaviour. Indeed, it has 
been reported that the ionic products of the dissolution of Si-, Ca- and Mg-containing 
bioactive ceramics could stimulate the growth, proliferation and osteogenic differentiation 
of mesenchymal stem cells [49, 87]. 
The morphology and organisation of hMSCs embedded within the hydrogels was 
assessed by labelling their actin filaments and nuclei and analysed by confocal microscopy. 
Data from day 21 of cell culture in both basal and osteogenic medium are shown in Figure 
22. 
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Figure 22 – Morphology and spatial arrangement of human mesenchymal stem cells embedded within 
composite hydrogels (D formulation) after 21 days of culture in basal or osteogenic medium, stained for 
F-actin (green) and nuclei (blue) (scale bars: 60 μm). 
 
From the analysis of Figure 22, it can be inferred that, similarly to the results 
obtained for the hydrogels containing fibroblasts (Figure 20), RGDpec provided an 
environment apparently more suitable for cell spreading and proliferation. Indeed, cells 
observed in gels prepared with BLKpec appear round-shaped whilst the ones in RGDpec 
hydrogels were able to spread and establish contact points between each other. Other 
studies that compared the morphology of hMSCs embedded into BLKpec and RGDpec 
hydrogels showed similar results, with clear differences between formulations at 14 days 
of culture [51]. Additionally, the mechanical properties of the materials also differ 
substantially (results presented below), with the present composite hydrogels displaying 
higher shear modulus elastic component values, which could limit cell’s ability to properly 
spread and grow. Regarding the effect of incubation of the cell-loaded hydrogels in basal 
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or osteogenic medium, no significant differences can be seen between the two 
compositions, which once more shows the composite’s ability to sustain the culture of 
mesenchymal stem cells for long periods of time. 
Rheological tests were performed onto hMSCs-embedded hydrogels after 
incubation for 1 and 14 days under both basal and osteogenic conditions (Figure 23). The 
influence of RGD presence or absence was also investigated (D formulation). 
 
 
Figure 23 – Shear modulus - elastic component (G’) - values of cell-laden composite hydrogels after 
incubation for 1 and 14 days under basal and osteogenic  conditions. Different symbols denote statistically 
significant differences between G’ values of different formulations for each time-point (p<0.05, n = 4). 
 
From the analysis of data shown in Figure 23, a very significant increase in G’ 
values after 14 days in culture was clearly noticeable, regardless of the medium in which 
the samples were incubated in or the type of pectin used. Comparing the results for the 
same formulation without cells at day 1 (section 4.3.1), it is possible to infer that the 
presence of the mesenchymal stem cells translated into a significant decrease in the 
mechanical properties of the composites. Neves et al. (2015) reported similar results to the 
ones presented here, with hMSCs-laden pectin hydrogels presenting lower shear moduli 
values comparing to materials without cells, possibly due to the physical interference of 
cells with the crosslinking process [51]. After 14 days of incubation, even though the 
formulation using RGDpec under osteogenic presented slightly higher shear modulus 
  
 
Manuel João Barros  Chapter 4 – Results and Discussion 
 
57 
 
 
values, every cell-loaded hydrogel exhibited a great increase in G’, possibly due to 
production of matrix. Further assays destined to characterize matrix deposition (such as 
analysis of collagen and fibronectin) would provide meaningful insight into the cell 
behaviour inside the composite. It should be noted that no major differences were observed 
between formulations cultured in the different media, once more showing that the 
material’s own composition provides the necessary ions for gel reinforcement and cell 
differentiation, removing the need of adding osteogenic supplements. 
Finally, to evaluate cell differentiation, namely mineralization induced by the 
hMSCs, a Von Kossa staining was also performed onto the cell-laden hydrogels. The 
mineralization was assessed after 7 and 21 days in basal or osteogenic medium (both 
BLKpec and RGDpec), as displayed in Figure 24. 
 
 
Figure 24 – Von Kossa staining of hMSC-laden composites after 7 and 21 days of incubation in basal and 
osteogenic medium (scale bar: 500 μm). 
 
After analysis of Figure 24 it can be clearly observed that the staining at day 21 
was significantly more intense than at day 7, independently of the culture medium, 
indicating some level of mineralization even for samples in basal medium, possibly due to 
the intrinsic osteogenic properties of the bioactive glass, as previously stated. In fact, 
Kapoor et al. (2015) reported similar studies of the differentiation capabilities of the Di-70 
with identical results, evidencing positive osteogenic markers for samples incubated with 
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hMSCs for 21 days without supplements [49]. These results are also consistent with the 
other tests performed to evaluate the biological behaviour of the embedded hMSCs and the 
in vitro differentiation capabilities of these composite materials, namely the assessment of 
cell metabolic activity and morphology and the material’s rheological properties, which 
suggested that no osteogenic supplement was needed to induce hMSCs osteogenic 
differentiation by virtue of the effect of the bioactive glass. In fact, this constitutes an 
advantage when comparing to pectin hydrogels without bioactive reinforcements, as it has 
been showed that adequate osteogenic conditions are necessary for the induction of cell 
differentiation along the osteoblastic lineage and for the nucleation of mineral phases in 
these cases [60, 62]. 
Overall, the produced hydrogel-bioactive glass composites proved to display 
excellent properties for bone tissue engineering, which simultaneously mitigate the 
drawbacks of both pectin and Di-70 bioactive glass alone. Indeed, the composite hydrogels 
exhibited the plasticity and versatility of the polymeric phase in addition to the intrinsic 
osteogenic properties of the ceramic phase, while ensuring a suitable environment for cell 
entrapment, growth, proliferation and differentiation over several weeks. It was possible to 
produce materials with tuneable properties and with in situ crosslinking ability within 
clinically relevant timeframes and without resorting to external crosslinking agents. In fact, 
not only does the material’s own composition provide the necessary ions for pectin 
gelation, but also promotes the differentiation of mesenchymal stem cells without 
additional osteogenic stimulation, resulting in a biocomposite suitable for bone tissue 
engineering applications as a cellularized biomaterial. 
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Chapter 5 
Conclusions and Future Work 
 
The present project aimed at fabricating hydrogel-bioactive glass composites, 
namely based on a pectin matrix, reinforced with bioactive glass particles, aiming at 
application in bone tissue engineering. The present work allowed to explore the 
mechanical and biological properties of a novel composite biomaterial, showing some of 
its advantages and limitations through a process of optimization of manufacturing 
parameters.  
A composite material based on RGD-functionalized pectin and a novel alkali-free 
formulation of bioactive glass microparticles (formulation of 70% diopside and 30% 
tricalcium phosphate; Di-70), composed of SiO2, CaO, MgO and P2O5, was successfully 
prepared, with a set of combined properties constituting an improvement of the original 
isolated materials: the composite has typically viscoelastic properties of polymers, 
although is stiffer than pectin alone; in terms of biological behaviour the composite 
provides an adequate environment for anchorage-dependent cell entrapment provided by 
RGD-pectin and offers conditions for osteogenic stimulation of stem cells provided by the 
bioactive glass microparticles. 
In fact, the production of materials with tuneable properties was achieved by 
altering the process parameters (including changes to polymer and glass content and 
bioactive glass particle size), which allowed for a better understanding of the hydrogel’s 
gelation process and how this affects the final properties of the material, namely their shear 
modulus values, swelling profile, biological compatibility and differentiation inducing 
properties. An important result was the production of pectin-based materials without the 
use of any crosslinking strategy, since crosslinking was provided by the divalent cations 
released by the bioactive glass used (namely calcium). Cell culture studies demonstrated 
that these materials are suitable for the entrapment of both fibroblasts and mesenchymal 
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stem cells (MSC), and promoted their attachment, proliferation and differentiation of 
MSCs during several weeks. An additional relevant result was the inherent osteogenic 
character of the materials developed, highly interesting for orthopaedic applications. Cell 
behaviour in general and differentiation in particular of entrapped MSCs was favoured in 
basal medium conditions, thus not requiring osteogenic stimulation, probably due to the 
release of calcium, phosphate and silicon ions from the glass, known for their 
osteogenicity. Additionally, the improved differentiation further contributed to the 
mechanical reinforcement of the materials by promoting increased matrix deposition and 
mineralization. 
This work demonstrated that the produced composites might be suitable for an 
additive manufacturing processing technique, as their controlled self-gelling ability allows 
for tight regulation of the processing parameters. An additive manufacturing technique 
such as 3D bioprinting would be of great interest as it allows for an accurate control of cell 
density in the materials. It would also allow for the production of materials with less 
batch-to-batch variability, being an automated process, while also promoting scalability. 
Additional work should be done in order to better comprehend the composite’s 
interactions with cells and culture medium for longer periods of time, and to mitigate the 
technical issues encountered throughout the development of this project. In particular, 
assays destined to characterize matrix deposition (e.g., collagen, fibronectin) by entrapped 
stem cells are necessary. It would also be interesting to take a step forward and, after the 
reproduction of several of these tests, try to advance to in vivo studies. 
Technical and time related restraints limited some of this work’s results. For 
example, ideally, MSCs should have been used in a lower passage to ensure their full 
differentiation potential, however this was not possible due to the great number of cells 
needed for the proposed assays.  
It would also be interesting to further analyse the composite’s structural features, in 
terms of the polymeric mesh size and the spatial distribution of the bioactive glass particles 
inside the matrix, by means of scanning electron microscopy and confocal raman 
microscopy techniques. 
Overall, this project’s main objective was reached, as the production of a composite 
biomaterial with potential uses in bone tissue engineering applications was achieved. 
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Additionally, the produced biocomposite showed promise as a cell-delivery system with in 
situ gelling capabilities within clinically acceptable time frames. 
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Annexes 
 
I – Calibration curve for RGD-grafting quantification 
 
 
Figure A1 – Calibration curve of absorbance values of pectin solutions containing increa singly higher RGD 
concentrations 
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Annexes 
 
II – Calibration curves for the quantification of Di-70’s components in complete 
α-MEM 
 
 
Figure A2 – Calibration curves of absorbance vs. different concentrations of calcium, phosphate, silicon and 
magnesium through spectrophotometric methods. 
 
 
  
 
Manuel João Barros  Annexes 
 
C 
 
 
Annexes 
 
III – Table of statistical analysis of data from Figure 19 
 
Parameter 1 vs Parameter 2 
Statistical  
Significance 
Day 1 – C – BLKpec vs Day 1 – C – RGDpec n.s. 
Day 1 – C – BLKpec vs Day 1 – D – BLKpec * 
Day 1 – C – BLKpec vs Day 1 – D – RGDpec * 
Day 1 – C – BLKpec vs Day 7 – C – BLKpec * 
Day 1 – C – RGDpec vs Day 1 – D – BLKpec n.s. 
Day 1 – C – RGDpec vs Day 1 – D – RGDpec n.s. 
Day 1 – C – RGDpec vs Day 7 – C – RGDpec * 
Day 1 – D – BLKpec vs Day 1 – D – RGDpec n.s. 
Day 1 – D – BLKpec vs Day 7 – D – BLKpec * 
Day 1 – D – RGDpec vs Day 7 – D – RGDpec * 
Day 7 – C – BLKpec vs Day 7 – C – RGDpec * 
Day 7 – C – BLKpec vs Day 7 – D – BLKpec * 
Day 7 – C – BLKpec vs Day 7 – D – RGDpec * 
Day 7 – C – RGDpec vs Day 7 – D – BLKpec * 
Day 7 – C – RGDpec vs Day 7 – D – RGDpec * 
Day 7 – D – BLKpec vs Day 7 – D – RGDpec n.s. 
 
Legend: * mark denotes statistical differences (p<0.05); n.s. means not statistically significant. 
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Annexes 
 
IV – Table of statistical analysis of data from Figure 21 
 
Parameter 1 vs Parameter 2 
Statistical 
Significance 
Day 1 – Basal – BLKpec vs Day 1 – Basal – RGDpec n.s. 
Day 1 – Basal – BLKpec vs Day 1 – Osteogenic – BLKpec n.s. 
Day 1 – Basal – BLKpec vs Day 1 – Osteogenic – RGDpec * 
Day 1 – Basal – BLKpec vs Day 14 – Basal – BLKpec * 
Day 1 – Basal – BLKpec vs Day 21 – Basal – BLKpec * 
Day 1 – Basal – RGDpec vs Day 1 – Osteogenic – BLKpec n.s. 
Day 1 – Basal – RGDpec vs Day 1 – Osteogenic – BLKpec n.s. 
Day 1 – Basal – RGDpec vs Day 14 – Basal – RGDpec n.s. 
Day 1 – Basal – RGDpec vs Day 21 – Basal – RGDpec n.s. 
Day 1 – Osteogenic – BLKpec vs Day 1 – Osteogenic – RGDpec n.s. 
Day 1 – Osteogenic – BLKpec vs Day 14 – Osteogenic – BLKpec * 
Day 1 – Osteogenic – BLKpec vs Day 21 – Osteogenic – BLKpec * 
Day 1 – Osteogenic – RGDpec vs Day 14 – Osteogenic – RGDpec n.s. 
Day 1 – Osteogenic – RGDpec vs Day 21 – Osteogenic – RGDpec n.s. 
Day 14 – Basal – BLKpec vs Day 14 – Basal – RGDpec * 
Day 14 – Basal – BLKpec vs Day 14 – Osteogenic – BLKpec * 
Day 14 – Basal – BLKpec vs Day 14 – Osteogenic – RGDpec * 
Day 14 – Basal – BLKpec vs Day 21 – Basal – BLKpec n.s. 
Day 14 – Basal – RGDpec vs Day 14 – Osteogenic – BLKpec * 
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Parameter 1 vs Parameter 2 
Statistical 
Significance 
Day 14 – Basal – RGDpec vs Day 14 – Osteogenic – RGDpec n.s. 
Day 14 – Basal – RGDpec vs Day 21 – Basal – RGDpec n.s. 
Day 14 – Osteogenic – BLKpec vs Day 14 – Osteogenic – RGDpec * 
Day 14 – Osteogenic – BLKpec vs Day 21 – Osteogenic – BLKpec * 
Day 14 – Osteogenic – RGDpec vs Day 21 – Osteogenic – RGDpec n.s. 
Day 21 – Basal – BLKpec vs Day 21 – Basal – RGDpec n.s. 
Day 21 – Basal – BLKpec vs Day 21 – Osteogenic – BLKpec * 
Day 21 – Basal – BLKpec vs Day 21 – Osteogenic – RGDpec * 
Day 21 – Basal – RGDpec vs Day 21 – Osteogenic – BLKpec * 
Day 21 – Basal – RGDpec vs Day 21 – Osteogenic – RGDpec n.s. 
Day 21 – Osteogenic – BLKpec vs Day 21 – Osteogenic – RGDpec * 
 
Legend: * mark denotes statistical differences (p<0.05); n.s. means not statistically significant. 
 
